|
1
|
Panagiotou A, Gaiao S and Cruz DN:
Extracorporeal therapies in sepsis. J Intensive Care Med.
28:281–295. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shane AL and Stoll BJ: Neonatal sepsis:
Progress towards improved outcomes. J Infect. 68 (Suppl
1)(S24-S32)2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Aziz M, Jacob A, Yang WL, Matsuda A and
Wang P: Current trends in inflammatory and immunomodulatory
mediators in sepsis. J Leukoc Biol. 93:329–342. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bosmann M and Ward PA: The inflammatory
response in sepsis. Trends Immunol. 34:129–136. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Burnham JP, Lane MA and Kollef MH: Impact
of sepsis classification and multidrug-resistance status on outcome
among patients treated with appropriate therapy. Crit Care Med.
43:1580–1586. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Carchman EH, Rao J, Loughran PA, Rosengart
MR and Zuckerbraun BS: Heme oxygenase-1-mediated autophagy protects
against hepatocyte cell death and hepatic injury from
infection/sepsis in mice. Hepatology. 53:2053–2062. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hotchkiss RS, Moldawer LL, Opal SM,
Reinhart K, Turnbull IR and Vincent JL: Sepsis and septic shock.
Nat Rev Dis Primers. 2(16045)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Martin GS: Sepsis, severe sepsis and
septic shock: Changes in incidence, pathogens and outcomes. Expert
Rev Anti Infect Ther. 10:701–706. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230.
2008.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Nakajima TE, Yamada Y, Hamano T, Furuta K,
Matsuda T, Fujita S, Kato K, Hamaguchi T and Shimada Y:
Adipocytokines as new promising markers of colorectal tumors:
Adiponectin for colorectal adenoma, and resistin and visfatin for
colorectal cancer. Cancer Sci. 101:1286–1291. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wichadakul D, Mhuantong W, Jongkaewwattana
A and Ingsriswang S: A computational tool for the design of live
attenuated virus vaccine based on microRNA-mediated gene silencing.
BMC Genomics. 13 (Suppl 7)(S15)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cui XS, Sun SC, Kang YK and Kim NH:
Involvement of microRNA-335-5p in cytoskeleton dynamics in mouse
oocytes. Reprod Fertil Dev. 25:691–699. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Huang J, Sun Z, Yan W, Zhu Y, Lin Y, Chen
J, Shen B and Wang J: Identification of microRNA as sepsis
biomarker based on miRNAs regulatory network analysis. Biomed Res
Int. 2014(594350)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Srivastava M, Khurana P and Sugadev R:
Lung cancer signature biomarkers: Tissue specific semantic
similarity based clustering of digital differential display (DDD)
data. BMC Res Notes. 5(617)2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dalamaga M: Nicotinamide
phosphoribosyl-transferase/visfatin: A missing link between
overweight/obesity and postmenopausal breast cancer? Potential
preventive and therapeutic perspectives and challenges. Med
Hypotheses. 79:617–621. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang B, Hasan MK, Alvarado E, Yuan H, Wu H
and Chen WY: NAMPT overexpression in prostate cancer and its
contribution to tumor cell survival and stress response. Oncogene.
30:907–921. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bi TQ, Che XM, Liao XH, Zhang DJ, Long HL,
Li HJ and Zhao W: Overexpression of Nampt in gastric cancer and
chemopotentiating effects of the Nampt inhibitor FK866 in
combination with fluorouracil. Oncol Rep. 26:1251–1257.
2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Daniel P, Leśniowski B, Mokrowiecka A,
Jasińska A, Pietruczuk M and Małecka-Panas E: Circulating levels of
visfatin, resistin and pro-inflammatory cytokine interleukin-8 in
acute pancreatitis. Pancreatology. 10:477–482. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
van der Poll T, van de Veerdonk FL,
Scicluna BP and Netea MG: The immunopathology of sepsis and
potential therapeutic targets. Nat Rev Immunol. 17:407–420.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vachharajani VT, Liu T, Wang X, Hoth JJ,
Yoza BK and McCall CE: Sirtuins link inflammation and metabolism. J
Immunol Res. 2016(8167273)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Baldwin AJ: The NF-kappa B and I kappa B
proteins: New discoveries and insights. Annu Rev Immunol.
14:649–683. 1996.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang ZM, Wan XH, Sang GY, Zhao JD, Zhu QY
and Wang DM: miR-15a-5p suppresses endometrial cancer cell growth
via Wnt/β-catenin signaling pathway by inhibiting WNT3A. Eur Rev
Med Pharmacol Sci. 21:4810–4818. 2017.PubMed/NCBI
|
|
24
|
Long J, Jiang C, Liu B, Fang S and Kuang
M: MicroRNA-15a-5p suppresses cancer proliferation and division in
human hepatocellular carcinoma by targeting BDNF. Tumour Biol.
37:5821–5828. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ergun S, Güney S, Temiz E, Petrovic N and
Gunes S: Significance of miR-15a-5p and CNKSR3 as novel prognostic
biomarkers in non-small cell lung cancer. Anticancer Agents Med
Chem. 18:1695–1701. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lee YJ, Choi DY, Choi IS, Kim KH, Kim YH,
Kim HM, Lee K, Cho WG, Jung JK, Han SB, et al: Inhibitory effect of
4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation,
amyloidogenesis and memory impairment via inhibition of nuclear
factor-kappaB in vitro and in vivo models. J Neuroinflammation.
9(35)2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hayes JB, Sircy LM, Heusinkveld LE, Ding
W, Leander RN, McClelland EE and Nelson DE: Modulation of
macrophage inflammatory nuclear factor κ (NF-κ) signaling by
intracellular cryptococcus neoformans. J Biol Chem.
291:15614–15627. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Van Huffel S, Delaei F, Heyninck K, De
Valck D and Beyaert R: Identification of a novel A20-binding
inhibitor of nuclear factor-kappa B activation termed ABIN-2. J
Biol Chem. 276:30216–30223. 2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bayne K: Revised guide for the care and
use of laboratory animals available. American Physiological
Society. Physiologist. 39(199): 208–211. 1996.PubMed/NCBI
|
|
30
|
Bai XZ, Zhang JL, Liu Y, Zhang W, Li XQ,
Wang KJ, Cao MY, Zhang JN, Han F, Shi JH and Hu DH: MicroRNA-138
aggravates inflammatory responses of macrophages by targeting SIRT1
and regulating the NF-κ and AKT pathways. Cell Physiol Biochem.
49:489–500. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen W, Ma X, Zhang P, Li Q, Liang X and
Liu J: MiR-212-3p inhibits LPS-induced inflammatory response
through targeting HMGB1 in murine macrophages. Exp Cell Res.
350:318–326. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang P, Zhang X, Li F, Yuan K, Li M, Zhang
J, Li B and Liang W: MiR-130b attenuates vascular inflammation via
negatively regulating tumor progression locus 2 (Tpl2) expression.
Int Immunopharmacol. 51:9–16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chithra MA, Ijinu TP, Kharkwal H, Sharma
RK, Pushpangadan P and George V: Phenolic rich Cocos nucifera
inflorescence extract ameliorates inflammatory responses in
LPS-stimulated RAW264.7 macrophages and toxin-induced murine
models. Inflammopharmacology. Jul 26. 2019.doi:
10.1007/s10787-019-00620-6 (Epub ahead of print). PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shou J, Kong X, Wang X, Tang Y, Wang C,
Wang M, Zhang L, Liu Y, Fei C, Xue F, et al: Tizoxanide inhibits
inflammation in LPS-Activated RAW264.7 macrophages via the
suppression of NF-κ and MAPK activation. Inflammation.
42:1336–1349. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ma A and Malynn BA: A20: Linking a complex
regulator of ubiquitylation to immunity and human disease. Nat Rev
Immunol. 12:774–785. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Huang L, Verstrepen L, Heyninck K,
Wullaert A, Revets H, De Baetselier P and Beyaert R: ABINs inhibit
EGF receptor-mediated NF-kappaB activation and growth of EGF
receptor-overexpressing tumour cells. Oncogene. 27:6131–6140.
2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Pelegrin P, Barroso-Gutierrez C and
Surprenant A: P2X7 receptor differentially couples to distinct
release pathways for IL-1beta in mouse macrophage. J Immunol.
180:7147–7157. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yonezawa Y, Miyashita T, Nejishima H,
Takeda Y, Imai K and Ogawa H: Anti-inflammatory effects of
olive-derived hydroxytyrosol on lipopolysaccharide-induced
inflammation in RAW264.7 cells. J Vet Med Sci. 80:1801–1807.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gao S, Wang Y, Li D, Guo Y, Zhu M, Xu S,
Mao J and Fan G: TanshinoneIIA alleviates inflammatory response and
directs macrophage polarization in lipopolysaccharide-stimulated
RAW264.7 cells. Inflammation. 42:264–275. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu F, Zhang X, Ling P, Liao J, Zhao M,
Mei L, Shao H, Jiang P, Song Z, Chen Q and Wang F: Immunomodulatory
effects of xanthan gum in LPS-stimulated RAW264. .7 macrophages.
Carbohydr Polym. 169:65–74. 2017.PubMed/NCBI View Article : Google Scholar
|
